Compass Pathways Plc ADR [CMPS] stock is trading at $4.81, up 3.00%. An important factor to consider is whether the stock is rising or falling in short-term value. The CMPS shares have gain 7.13% over the last week, with a monthly amount drifted -9.25%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Compass Pathways Plc ADR [NASDAQ: CMPS] stock has seen the most recent analyst activity on July 23, 2024, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $23. Previously, Morgan Stanley started tracking the stock with Overweight rating on April 01, 2024, and set its price target to $30. On December 12, 2023, Deutsche Bank initiated with a Buy rating and assigned a price target of $16 on the stock. Loop Capital initiated its recommendation with a Buy and recommended $34 as its price target on November 01, 2022. Oppenheimer started tracking with a Outperform rating for this stock on October 29, 2021, and assigned it a price target of $50. In a note dated July 13, 2021, Citigroup initiated an Buy rating and provided a target price of $67 on this stock.
Compass Pathways Plc ADR [CMPS] stock has fluctuated between $4.00 and $12.75 over the past year. Currently, Wall Street analysts expect the stock to reach $23 within the next 12 months. Compass Pathways Plc ADR [NASDAQ: CMPS] shares were valued at $4.81 at the most recent close of the market. An investor can expect a potential return of 378.17% based on the average CMPS price forecast.
Analyzing the CMPS fundamentals
Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -45.76%, Pretax Profit Margin comes in at -39.92%, and Net Profit Margin reading is -39.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.58, Equity is -0.64 and Total Capital is -0.76. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.68 points at the first support level, and at 4.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.92, and for the 2nd resistance point, it is at 5.04.
Ratios To Look Out For
For context, Compass Pathways Plc ADR’s Current Ratio is 8.91. On the other hand, the Quick Ratio is 8.91, and the Cash Ratio is 7.9.
Transactions by insiders
Recent insider trading involved ATAI Life Sciences N.V., 10% Owner, that happened on Sep 26 ’24 when 2.66 million shares were sold. 10% Owner, Malievskaia Ekaterina completed a deal on May 21 ’24 to sell 8900.0 shares. Meanwhile, 10% Owner Malievskaia Ekaterina sold 8900.0 shares on May 21 ’24.
